MedTrace Logo

Pain Management After Cesarean Section - A Before-and-After Cohort Study

NCT06813638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-11-28

No results posted yet for this study

Summary

Inadequate pain relief remains a challenge after Cesarean section (CS) and may significantly impair postoperative recovery. A recent Danish single-center study (n=100) revealed that 66% of elective CS patients experienced severe pain (NRS ≥ 7) during the first 24 hours, with the highest pain scores occurring within the initial 12 hours.

To optimize postoperative pain management for CS patients at the same study center, the investigators have implemented recommendations for pain management from the PROSPECT guideline for procedure-specific postoperative pain management after CS, as recommended by the European Society of Regional Anaesthesia \& Pain Therapy.

The study center had already been adhering to the guidelines concerning postoperative care and surgical technique. The investigators have now implemented the second PROSPECT recommendation, focusing on the intraoperative management after delivery, and implemented wound infiltration in combination with an ilio-inguinal field block, before closing the incision after CS, and intravenous dexamethasone (8mg), administered immediately after birth of the baby during CS.

The investigators designed a before-and-after study with the aim of investigating whether the new practice of adding wound infiltration, an ilio-inguinal field block, and intravenous dexamethasone intraoperatively reduces the incidence of postoperative pain in the early period following CS.

Conditions

  • Cesarean Section
  • Cesarean Delivery
  • Pain Management
  • Pain Management in Postoperative Care
  • Postoperative Pain
  • Cohort Study
  • Text Message
  • Patient Reported Outcome
  • Wound Infiltration

Sponsors & Collaborators

  • Nordsjaellands Hospital

    lead OTHER

  • Hillerod Hospital, Denmark

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

Principal Investigators

  • Patricia Duch, MD · Department of Anaesthesia, University Hospital of Copenhagen, Northern Zealand

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-06-10
Completion
2025-06-10

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06813638 on ClinicalTrials.gov